Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

736
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
736
Inflammation01:38

Inflammation

64.0K
Overview
64.0K
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

1.9K
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
1.9K
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

1.1K
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
1.1K
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

1.6K
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.6K
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

731
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
731

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Optimizing antihypertensive therapy in patients with diabetes mellitus.

Hypertension research : official journal of the Japanese Society of Hypertension·2022
Same author

JCS/JACR 2021 Guideline on Rehabilitation in Patients With Cardiovascular Disease.

Circulation journal : official journal of the Japanese Circulation Society·2022
Same author

New quantitative indices of cardiac amyloidosis with <sup>99m</sup>Tc-pyrophosphate scintigraphy.

Japanese journal of radiology·2022
Same author

NLRP3 Inflammasome Activation Through Heart-Brain Interaction Initiates Cardiac Inflammation and Hypertrophy During Pressure Overload.

Circulation·2022
Same author

Isoproterenol loading transesophageal echocardiography in atrial fibrillation.

The international journal of cardiovascular imaging·2022
Same author

Effect of ipragliflozin on carotid intima-media thickness in patients with type 2 diabetes: a multicenter, randomized, controlled trial.

European heart journal. Cardiovascular pharmacotherapy·2022

Related Experiment Video

Updated: Mar 24, 2026

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
10:03

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty

Published on: January 28, 2020

5.9K

Inflammatory Biomarkers and Atherosclerosis.

Takeshi Soeki1, Masataka Sata

  • 1Department of Cardiovascular Medicine, Institute of Biomedical Sciences, Tokushima University Graduate School.

International Heart Journal
|March 15, 2016
PubMed
Summary

This review explores inflammatory biomarkers for atherosclerosis and cardiovascular risk. It discusses established markers like C-reactive protein (CRP) and novel targets for anti-atherosclerotic therapies.

Area of Science:

  • Cardiovascular Research
  • Inflammation Biology
  • Biomarker Discovery

Background:

  • Atherosclerosis is characterized by chronic vascular inflammation.
  • Inflammatory biomarkers are crucial for monitoring cardiovascular risk.
  • C-reactive protein (CRP) is a well-established but non-specific inflammatory marker.

Purpose of the Study:

  • To review established and novel inflammatory biomarkers for atherosclerosis.
  • To highlight biomarkers reflecting local atherosclerotic inflammation.
  • To explore the therapeutic potential of inflammatory biomarkers in anti-atherosclerotic strategies.

Main Methods:

  • Literature review of established and novel inflammatory biomarkers.
  • Analysis of biomarker specificity and clinical utility.

More Related Videos

A Human Ex Vivo Atherosclerotic Plaque Model to Study Lesion Biology
05:51

A Human Ex Vivo Atherosclerotic Plaque Model to Study Lesion Biology

Published on: May 6, 2014

13.8K
On-Chip Endothelial Inflammatory Phenotyping
12:43

On-Chip Endothelial Inflammatory Phenotyping

Published on: July 21, 2012

11.5K

Related Experiment Videos

Last Updated: Mar 24, 2026

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
10:03

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty

Published on: January 28, 2020

5.9K
A Human Ex Vivo Atherosclerotic Plaque Model to Study Lesion Biology
05:51

A Human Ex Vivo Atherosclerotic Plaque Model to Study Lesion Biology

Published on: May 6, 2014

13.8K
On-Chip Endothelial Inflammatory Phenotyping
12:43

On-Chip Endothelial Inflammatory Phenotyping

Published on: July 21, 2012

11.5K
  • Discussion of biomarker roles in therapeutic development.

    • Main Results:

    • C-reactive protein (CRP) is a widely studied biomarker but has limitations due to non-specific responses.
    • Novel biomarkers offer greater specificity for local atherosclerotic inflammation.
    • Inflammatory biomarkers show promise for guiding anti-atherosclerotic treatments.

    Conclusions:

    • While CRP is a recognized marker, novel biomarkers are needed for accurate cardiovascular risk assessment.
    • Targeting local atherosclerotic inflammation via specific biomarkers is a promising therapeutic avenue.
    • Further research into inflammatory biomarkers can advance the development of effective anti-atherosclerotic therapies.